Loading...
Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
On July 2, 2009, the U.S. Food and Drug Administration approved pemetrexed injection (Alimta® Injection; Eli Lilly and Company, Indianapolis, IN) for maintenance treatment of patients with locally advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after fo...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227931/ https://ncbi.nlm.nih.gov/pubmed/21148615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0224 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|